Brief: Akoya Biosciences Q1 Gross Margin 59.3%
12/05/2025 21:05
May 12 (Reuters) - Akoya Biosciences Q1 revenue USD 16.6 million vs. IBES estimate USD 19.9 million.
Recent news on Akoya Biosciences
See all newsBrief: Akoya Biosciences Inc - On May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing
Akoya Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Akoya Biosciences Q1 Gross Margin 59.3%
Akoya Biosciences Inc expected to post a loss of 20 cents a share - Earnings Preview
Leerink Partners downgrades Quanterix to 'market perform' on Akoya deal risks